Magnetic Resonance Imaging of Breast Cancer
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age21+
SponsorStanford University
About this trial
To compare magnetic resonance imaging (MRI) with more well established diagnostic imaging techniques to determine which method best finds and defines breast cancer.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Female
Documented breast physical examination,
Documented mammography within 3 months of the MR studies
Palpable or mammographically-detected suspect breast lesions
Disqualifiers
Male by birth
Able to complete the MR examination. Subjects will be interviewed by one of the investigators for the usual contraindications to
MR contraindications including
Pacemakers
Trial design
Design model
Single group
Treatments tested in this trial
MRI
Procedure/Surgery
Treatment groups
500 Participants
are divided into 1 treatment groupGroup A: Magnetic Resonance Imaging (MRI) of Breast CancerExperimental treatment 1 intervention
Trial outcomes
Primary outcomes
1
To compare magnetic resonance imaging (MRI) with more well established diagnostic imaging techniques to determine which method best finds and defines breast cancer.
Time frame
Length of one MRI scanSponsors and contacts
Click on the lead sponsor to view all of their trials.
Stanford University
Lead sponsor
National Cancer Institute (NCI)
Collaborator
National Institutes of Health (NIH)
Collaborator
National Institute for Biomedical Imaging and Bioengineering (NIBIB)
Collaborator
Source ClinicalTrials.gov